Exact Mass: 417.98325679999994
Exact Mass Matches: 417.98325679999994
Found 36 metabolites which its exact mass value is equals to given mass value 417.98325679999994,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cefalotin sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Roflumilast N-oxide
C17H14Cl2F2N2O4 (418.02986480000004)
Roflumilast N-oxide is a metabolite of roflumilast. Roflumilast (trade names Daxas, Daliresp) is a drug which acts as a selective, long-acting inhibitor of the enzyme PDE-4. It has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such as asthma, and chronic obstructive pulmonary disease (COPD). (Wikipedia)
2-((2-((Dimethoxyphosphorothioyl)thio)-4-ethoxy-4-oxobutanoyl)oxy)-2-methylmalonic acid
(2,4-dichlorophenyl)-[5-[5-(2,4-difluorophenyl)furan-2-yl]pyrazol-1-yl]methanone
C20H10Cl2F2N2O2 (418.00873640000003)
1H,1H,2H,2H-Perfluorooctyl acrylate
C11H7F13O2 (418.02384379999995)
[4-(2-bromoacetyl)phenyl] anthracene-9-carboxylate
Roflumilast N-oxide
C17H14Cl2F2N2O4 (418.02986480000004)
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058988 - Phosphodiesterase 4 Inhibitors
1-[[(4-METHYLPHENYL)SULPHONYL]OXY]-1,2-BENZIODOXOL-3(1H)-ONE
C14H11IO5S (417.93719460000005)
2-bromoethyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate
sodium 4,5-dichloro-2-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate
C16H9Cl2N2NaO4S (417.95577740000004)
1,4-BIS(2,2,2-TRIFLUOROETHOXY)-2-(TRICHLOROACETYL)BENZENE
2-methyl-1H-inden-1-ide,zirconium(4+),dichloride
C20H18Cl2Zr (417.98325679999994)
Ethyl-2-(2,6-dichlor-5-fluorpyridin-3-carbonyl)-3-(2,4-difluorphenylamino)-acrylat
RAC-ETHYLENEBIS(INDENYLZIRCONIUM DICHLORIDE
C20H18Cl2Zr (417.98325679999994)
Calcium dobesilate
C12H10CaO10S2 (417.93413100000004)
C - Cardiovascular system > C05 - Vasoprotectives > C05B - Antivaricose therapy COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics C78274 - Agent Affecting Cardiovascular System Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-(5-Chlorobenzofuran-2-carbonyl)-2-(trifluoromethyl)benzenesulfonohydrazide
C16H10ClF3N2O4S (418.00018860000006)
[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] methyl hydrogen phosphate
N-[3-[(5-bromo-3-chloro-6-oxo-1-cyclohexa-2,4-dienylidene)methylamino]phenyl]-2-furancarboxamide
C18H12BrClN2O3 (417.97197719999997)
Glucoraphenin(1-)
C12H20NO9S3- (418.03001700000004)
A glucosinolate resulting from the removal of the proton from the oxime hydrogen sulfate group of glucoraphenin.
3-Hydroxy-4-sulooxy-5-(2,3,4,5-tetrahydroxybenzoyl)oxybenzoic acid
C14H10O13S (417.98421300000007)
Cephalothin Sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
TDP
A pyrimidine ribonucleoside 5-diphosphate in which the pyrimidine element is 5-methyluracil.